PDCD1 and colorectal cancer: For those colorectal cancer patients, a combination of anti-PD1 with drugs targeting myeloid-derived suppressor cells or a combination of drugs targeting other co-expressed inhibitors could be considered (Kuang et al., 2020; Lind et al., 2020; Zhang et al., 2020).